Reaffirming 2026 guidance ranges Advancing Bring Your Own Power strategy with hyperscaler for 1.2 GW CCGT in Texas Achieved commercial operations at 415 MW T.H. Wharton facility, NRG's first new build generation asset in nearly a decade; remaining two Texas Energy Fund projects on time and on budget NRG Energy, Inc. (NYSE:NRG) today announced financial results for the second quarter ended June 30, 2026, and reports GAAP Net Income of $506 million, GAAP Earnings per Share (EPS) — basic of $2.32, and GAAP Cash Provided by Operating Activities of $1,117 million. The Company's non-GAAP metrics are Adjusted Net Income of $315 million, Adjusted EPS of $1.49, Adjusted EBITDA of $1,217 mi
Press Releases
Delayed 3mFastest customizable press release feed in the world.
Signed out · 3-min delay · Sign up for real-time
- NRG Energy Reports Second Quarter 2026 Results and Reaffirms 2026 Financial Guidance
- PSEG ANNOUNCES SECOND QUARTER 2026 RESULTS
$0.67 PER SHARE NET INCOME$0.86 PER SHARE NON-GAAP OPERATING EARNINGS Maintains 2026 Non-GAAP Operating Earnings Guidance of $4.28 - $4.40 Per ShareNEWARK, N.J., Aug. 4, 2026 /PRNewswire/ -- Public Service Enterprise Group (NYSE:PEG) reported the following results for the second quarter and six months ended June 30, 2026: PSEG Consolidated (unaudited)Second Quarter Comparative Results IncomeEarnings Per Share($ millions, except per share amounts)2026202520262025Net Income $334$585$0.67$1.17 Reconciling Items 91(201)0.19(0.40)Non-GAAP Operating Earnings$425$384$0.86$0.77 Average Shares Outstanding (Diluted)499500See Attachme
- Dario Expands Provider-Backed Cardiometabolic Platform with New Women's Health and Sleep Solutions Aligning with Client Demand
New programs, expected to begin revenue contribution Q4 2026, extend Dario's integrated healthcare platform into two high-impact clinical categories while advancing execution of the Company's provider-backed care strategyAI-enabled programs combine digital engagement, human behavioral coaching and clinical care to improve outcomes while expanding Dario's participation in reimbursement-driven healthcare servicesNEW YORK, Aug. 4, 2026 /PRNewswire/ -- DarioHealth Corp. (NASDAQ:DRIO) (the "Company", "DarioHealth" or "Dario"), a leading AI-powered healthcare technology company transforming the management of chronic conditions, today announced it has further expanded its provider-backed cardiometa
- Conagra Brands Appoints Amy Held as Executive Vice President and Chief Administrative Officer
Newly created role will include oversight of Human Resources and Corporate Communications and will report to president and CEO John BraseCHICAGO, Aug. 4, 2026 /PRNewswire/ -- Conagra Brands, Inc. (NYSE:CAG) today announced the appointment of Amy Held as executive vice president and chief administrative officer, a newly created role designed to streamline key corporate functions, effective September 14. In this position, Held will oversee human resources and corporate communications and will serve as chief of staff, reporting directly to president and chief executive officer John Brase. Conagra also announced that Charisse Brock, executive vice president and chief human resources officer, wil
- Wingstop Saddles Up for the Flavor Rodeo with BBQ Favorites, Carolina Gold and Jamaican Jerk
To celebrate the returning flavors, Wingstop introduces the first-ever Delivery Cowboy experience, plus $0 delivery with qualifying purchase from Aug. 14-16 using code GIDDYUPDALLAS, Aug. 4, 2026 /PRNewswire/ -- Wingstop (NASDAQ:WING) is saddling up for the Flavor Rodeo, bringing fan-favorites Carolina Gold and Jamaican Jerk back to menus nationwide* after prior limited-time runs. The flavors will be available exclusively to Club Wingstop members starting Aug. 7, and to all fans beginning Aug. 11, alongside two new additions: Hot Honey Mustard Dip and Sprite Strawberry Rodeo**, available exclusively at Wingstop locations featuring Coca-Cola Freestyle dispensers nationwide.
- CME Group July Volume Hits New Record of 27 Million Contracts, Up 23% Year Over Year
Record July ADV in interest rate, equity index, energy, agricultural and metals productsInternational ADV grew 32% to 8.8 million contractsCHICAGO, Aug. 4, 2026 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its highest July average daily volume (ADV) on record at 27 million contracts, an increase of 23% year-over-year. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume. July 2026 ADV across asset classes includes:Interest Rate ADV of 12.6 million contractsEquity Index ADV of 8.2 million contractsEnergy ADV of 2.6 million contractsAgricultural ADV of 2 million contractsForeign Exchange ADV of 811,000 con
- MDA SPACE AWARDED $474 MILLION TO EXPAND THE TELESAT LIGHTSPEED LEO CONSTELLATION
Follow-on order of MDA AURORA™ satellites will enable Telesat to meet the needs of both commercial and defence customersTORONTO, Aug. 4, 2026 /CNW/ -- MDA Space Ltd. (TSX:MDA) (NYSE:MDA), a trusted mission partner to the rapidly expanding global space industry, will be supplying Telesat LEO ULC, a division of Telesat Corporation (NASDAQ:TSAT) (TSX:TSAT) with additional MDA AURORA™ next-generation broadband satellites, coinciding with the operator's announcement today that it is expanding the Telesat Lightspeed low Earth orbit constellation. Telesat announced that it is expanding its LEO constellation by 69 satellites, bringing
- ImmunityBio Reports Record Q2 2026 Net Product Revenue of $50.7 Million, Up 92% Year-Over-Year; First-Half Revenue Up 121% to $94.8 Million
Q2 2026 net product revenue of $50.7 million, up 92% year-over-year and 15% sequentially from Q1 2026, marking the eighth consecutive quarter of sequential revenue growth since the commercial launch of ANKTIVA®, driven by continued adoption among U.S. urologists and strong market access First-half 2026 net product revenue of $94.8 million, up 121% compared with the first-half of 2025 In July 2026, we announced the Emirates Drug Establishment of the United Arab Emirates granted the broadest marketing authorization for ANKTIVA across BCG-unresponsive NMIBC for CIS and papillary disease and metastatic NSCLC The FDA accepted for review the Company’s supplemental Biologics License Appl
- Turning Point Brands Announces Second Quarter 2026 Results
Q2 2026 Modern Oral Gross Revenue increased 149% to $87.0 million and Net Sales increased 128% to $68.4 million. Accounting for 48% of total company net sales, up from 26% in Q2 2025 Raising FY 2026 Modern Oral Gross and Net Sales guidance Turning Point Brands, Inc. ("TPB" or "the Company") (NYSE:TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and consumables with active ingredients, today announced financial results for the second quarter ended June 30, 2026. Q2 2026 Financial Highlights (All results reflect comparisons to prior-year period) Total Consolidated Net Sales increased 22.6% to $142.9 million S
- FIS Reports Second Quarter 2026 Results
Second quarter GAAP Diluted EPS of $0.45 Adjusted EPS of $1.48 increased 8.8% over the prior year period Revenue increased 29% on a GAAP basis to $3.4 billion, increasing 31% on an adjusted basis and 5.3% on a Pro Forma basis Net cash provided by operating activities was $493 million and Free cash flow1 was $525 million, increasing 220% Updated full-year 2026 outlook, including Adjusted revenue growth of 29 - 30%, Adjusted EBITDA growth of 32 - 34%, Adjusted EPS growth of 7.0 - 8.5% and Free Cash Flow1 growth of 33 - 39%, to $2,150 - $2,250 million2 Updated 2026 outlook for Pro Forma revenue growth to 4.5 - 5.0%, as compared to 5.1 - 5.7% and Pro Forma Adjusted EBITDA growth
- Sunoco LP and SunocoCorp LLC Report Strong Second Quarter 2026 Financial and Operating Results
Reports strong second quarter results, including net income of $283 million, Adjusted EBITDA(1) of $996 million, excluding one-time transaction-related expenses(2), and Distributable Cash Flow, as adjusted(1), of $608 million Increases full year 2026 Adjusted EBITDA guidance by $400 million to $3.5 billion to $3.7 billion Sunoco LP (NYSE:SUN) ("SUN" or the "Partnership") and SunocoCorp LLC (NYSE:SUNC) ("SUNC") today reported financial and operating results for the quarter ended June 30, 2026. Financial and Operational Highlights Attributable to Sunoco LP Net income for the second quarter of 2026 was $283 million compared to $86 million in the second quarter of 2025. Adjusted EB
- Thryv Reports Second Quarter 2026 Results and Launches Thryv Growth Platform
Q2 SaaS Revenue Grows to 76% of Total Revenue Q2 SaaS Monthly ARPU Increases 12% Year-Over-Year to $394 Company Announces Strategic Restructuring Plan to Improve Operating Efficiencies Thryv Holdings, Inc. (NASDAQ:THRY) ("Thryv" or the "Company"), the provider of Thryv®, an AI-native growth platform for local service businesses, reported results for the second quarter of 2026. "Our second quarter marked another step forward in the transformation of our business, with SaaS now representing 76% of our revenue and ARPU growing 12% year-over-year," said Joe Walsh, Thryv Chairman and CEO. "Our SaaS profile now reflects our deliberate focus on the newly launched Thryv Growth Platform,
- Energy Transfer Reports Second Quarter 2026 Results and Updates 2026 Financial Guidance
Energy Transfer LP (NYSE:ET) ("Energy Transfer" or the "Partnership") today reported financial results for the quarter ended June 30, 2026. Energy Transfer reported net income attributable to partners for the three months ended June 30, 2026 of $2.09 billion compared to $1.16 billion for the three months ended June 30, 2025. For the three months ended June 30, 2026, net income per common unit (basic) was $0.59. Adjusted EBITDA for the three months ended June 30, 2026 was $5.07 billion compared to $3.87 billion for the three months ended June 30, 2025, an increase of 31%. Distributable Cash Flow attributable to partners, as adjusted, for the three months ended June 30, 2026 was $2.59 b
- Fortitude Completes Acquisition of 12.5 MW Prosser, Nebraska Facility
Advances Fortitude's venture mining strategy and further strengthens its owned power portfolio Acquisition marks latest milestone as Fortitude advances toward public markets through proposed combination with HeartSciences (NASDAQ:HSCS) Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, today announced that it has completed the acquisition of a 12.5 megawatt ("MW") digital infrastructure facility in Prosser, Nebraska (the "Prosser Facility") in an asset purchase of the underlying real property. The transaction was funded entirely with cash on the Company's balance sheet. This press release features multimedia. View the
- Cummins Reports Strong Second Quarter 2026 Results; Raises Full-Year Outlook
Record second-quarter revenues of $9.5 billion; GAAP1 Net Income of $932 million, or 9.9% of sales EBITDA2 in the second quarter was 17.5% of sales; Diluted EPS of $6.73 Full-year revenues are expected to range from up 10% to up 13%, an improvement from prior guidance of up 8% to 11% EBITDA is now expected to be in the range of 18.0% to 18.5%, compared to prior guidance of 17.75% to 18.5% The company returned $501 million to shareholders in the second quarter in the form of cash dividends and share repurchases Cummins Inc. (NYSE:CMI) today reported results for the second quarter of 2026. "Cummins delivered record second-quarter results, reflecting robust customer orders fo
- Albany International Reports Second-Quarter 2026 Results
Q2 2026 net revenue of $329.5 million, up 6% compared to $311.4 million in Q2 2025. Q2 2026 net income attributable to the Company of $17.4 million, or diluted earnings per share (EPS) of $0.61, up 90% and 97% respectively, compared to net income of $9.2 million, or diluted EPS of $0.31, in the prior year. Adjusted EBITDA of $57.8 million in Q2 2026 and Adjusted EPS per diluted share of $0.82 up 11% and 45% respectively, compared to $51.9 million and $0.57 in Q2 2025. Paid $7.9 million in dividends and invested $11.9 million in capital in the second quarter, continuing the commitment of balanced capital allocation. Albany International Corp. (NYSE:AIN) today reported operating
- Venu Holding Corporation to Host Fiscal 2026 Second Quarter Earnings Call
Venu Holding Corporation ("VENU" or the "Company") (NYSE:VENU), owner, operator, and developer of premium live entertainment destinations, will host a conference call to discuss financial results and strategic initiatives for its fiscal second quarter ended June 30, 2026, on Thursday, August 13 at 11:00 a.m. Eastern Time. The Company will issue a press release reporting its results prior to market opening. Conference Call Details Thursday, August 13, 2026, at 11:00 a.m. Eastern Time North America Toll Free Dial-In Number +1 833-461-5787 International Toll Dial-In Number +1 585-542-9983 Meeting ID 512 667 005 Webcast Link https://
- Creative Realities, Inc. Announces Second Quarter 2026 Earnings Release Date and Conference Call Information
LOUISVILLE, Ky., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ:CREX), a leading provider of digital signage and media solutions, announced today that it will release its financial results for the three months ended June 30, 2026 before the market open on Thursday, August 13, 2026. A conference call to review the results is scheduled for Thursday, August 13, 2026, at 9:00 am Eastern Time, which will include prepared remarks and materials from management followed by a live Q&A. The call will be hosted by Rick Mills, Chairman and Chief Executive Officer, Tamra Koshewa, Chief Financial Officer and George Sautter, Chief Strate
- Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
First module of the rolling NDA for QTORIN™ rapamycin for microcystic lymphatic malformations submitted to FDA, with completion of the NDA submission on track for the second half of 2026 Preparing for a planned standalone U.S. commercial launch of QTORIN™ rapamycin for microcystic lymphatic malformations in the first half of 2027, if approved Initiation of Phase 3 trial of QTORIN™ rapamycin for the treatment of cutaneous venous malformations planned for the fourth quarter of 2026 Initiation of Phase 2 trial of QTORIN™ pitavastatin for the treatment of disseminated superficial actinic porokeratosis planned for the second half of 2026 Topline results from the Phase 2 LOTU t
- Zevra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NASDAQ:ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases, today announced that members of Zevra’s executive leadership team will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on Tuesday, August 11, 2026, at 11:00 a.m. ET. Additionally, management will be available for one-on-one meetings with registered conference attendees. A link to the live webcast will be accessible on the "Events & Presentations" page in the Investor Relations section of Zevra’s website at investors.zevra.com. About Zevra Therape